Alimera reports $8.6 million net loss in second quarter

Alimera Sciences reported GAAP net loss applicable to common stockholders of $8.6 million, or $0.19 per share, in the second quarter compared with GAAP net income of $1.1 million, or $0.03 per share, in the second quarter of 2014, according to a press release.The loss was attributed to non-cash items that included changes in the fair value of a derivative warrant liability, unrealized gains and losses in foreign currency, and reserves for potential inventory expiration, the release said.

Full Story →